Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease
Click here to claim CME/NCPD credit for this acti…
Oncology Data Advisor · i3 Health
May 23, 20231h 11m
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Click here to claim CME/NCPD credit for this activity: https://i3health.com/oda-gvhd
This audio includes both the additional updates interview and complete podcast from i3 Health’s CME/NCPD activity New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease.
First, listen along as Dr. Shernan Holtan shares the latest data from the BTM CTN 1703 trial of posttransplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as GVHD prophylaxis after allogeneic hematopoietic cell transplantation, then stay tuned after the interview to listen along to the full activity.